-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Biomarin Pharmaceutical Inc quarterly/annual Depreciation history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc Depreciation for the quarter ending June 30, 2024 was $11.5M, a 22.3% increase year-over-year.
- Biomarin Pharmaceutical Inc Depreciation for the twelve months ending June 30, 2024 was $44.7M, a 20.5% increase year-over-year.
- Biomarin Pharmaceutical Inc annual Depreciation for 2023 was $40.3M, a 4.4% increase from 2022.
- Biomarin Pharmaceutical Inc annual Depreciation for 2022 was $38.6M, a 16.3% decline from 2021.
- Biomarin Pharmaceutical Inc annual Depreciation for 2021 was $46.1M, a 7.21% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)